Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncology. 2011;81(1):9-11. doi: 10.1159/000330814. Epub 2011 Sep 2.

Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients.

Author information

1
Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Abstract

OBJECTIVE:

This study reports the percentage of breast cancer survivors receiving ongoing benzodiazepines and the circumstances surrounding their usage.

METHODS:

The medical records of 1,000 consecutive breast cancer survivors who were no longer receiving adjuvant chemotherapy were reviewed.

RESULTS:

Among those patients, 7.9% (95% confidence interval 6.2-9.6; higher than the 3% rate in the general population) were receiving benzodiazepines. Lorazepam was most commonly prescribed. Sixty-eight patients were cancer free at their last visit, and 51 had not been taking benzodiazepines prior to their cancer diagnosis. Anxiety was the single most frequent reason for initiating and continuing benzodiazepines.

CONCLUSION:

Anxiety appears to be a common explanation for relatively high rates of benzodiazepine use in breast cancer survivors. This finding merits further study.

PMID:
21894050
PMCID:
PMC3186715
DOI:
10.1159/000330814
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
    Loading ...
    Support Center